http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102252163-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-735 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16171 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16151 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16134 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2760-16122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-91 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005 |
filingDate | 2014-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-102252163-B1 |
titleOfInvention | Influenza virus vaccines and uses thereof |
abstract | The present invention is covalent to the HA1 C-terminal stem segment comprising (a) amino acids from position y of the HA1 domain to the C-terminal amino acid including the C-terminal amino acid by a linking sequence of 0 to 50 amino acid residues. An influenza hemagglutinin HA1 domain comprising an HA1 N-terminal stem segment comprising an amino acid from position 1 to position x, preferably from position p to position x, of the connected HA1 domain, and (b) an influenza hemagglutinin HA2 domain. It provides an influenza hemagglutinin stem domain polypeptide comprising, wherein the hemagglutinin stem domain polypeptide is resistant to protease cleavage at the junction between HA1 and HA2, wherein positions 337, 340, 352, 353, 402, 406, At least one of the amino acids at 409, 413 and/or 416 is mutated relative to the corresponding position in wild-type influenza HA. |
priorityDate | 2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1125.